Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.00%454.79B | -0.38%1.88T | 4.12%464.06B | 12.71%1.89T | 5.83%479.68B | 16.48%489.6B | 10.09%476.55B | 19.91%445.68B | 17.48%1.68T | 11.51%453.24B |
| Cost of revenue | -3.65%385.68B | -0.28%1.6T | 5.08%400.3B | 12.97%1.61T | 8.22%403.33B | 14.29%409B | 11.99%414.29B | 18.13%380.96B | 16.78%1.42T | 7.78%372.69B |
| Gross profit | 8.40%69.11B | -0.93%281.29B | -1.50%63.76B | 11.28%283.93B | -5.22%76.35B | 29.04%80.59B | -1.08%62.26B | 31.57%64.72B | 21.57%255.15B | 32.77%80.55B |
| Operating expense | 5.66%55.59B | 9.52%242.84B | 14.70%52.61B | 7.73%221.73B | 11.14%71.51B | 20.12%57.85B | -1.07%46.5B | -0.97%45.87B | 18.64%205.82B | 35.55%64.34B |
| Selling and administrative expenses | -0.20%55.08B | 2.52%216.35B | 8.75%55.19B | 9.63%211.03B | 16.04%58.01B | 18.91%57.57B | -5.91%44.71B | 8.98%50.74B | 14.90%192.49B | 14.70%49.99B |
| -General and administrative expense | -0.20%55.08B | 2.52%216.35B | 8.75%55.19B | 9.63%211.03B | 16.04%58.01B | 18.91%57.57B | -5.91%44.71B | 8.98%50.74B | 14.90%192.49B | 14.70%49.99B |
| Other operating expenses | 36.89%2.1B | 55.75%34.48B | -3.76%1.54B | 2.39%22.14B | -16.72%15.17B | -18.38%1.03B | 296.26%4.35B | 51.37%1.6B | 45.27%21.62B | 135.41%18.21B |
| Total other operating income | -61.24%1.59B | -30.09%8B | -36.46%4.11B | 37.94%11.44B | -56.90%1.67B | -51.09%737M | 58.05%2.56B | 399.00%6.47B | -7.25%8.29B | 0.21%3.87B |
| Operating profit | 21.36%13.53B | -38.17%38.45B | -40.89%11.15B | 26.09%62.2B | -70.17%4.84B | 59.07%22.74B | -1.12%15.77B | 556.09%18.86B | 35.51%49.33B | 22.76%16.21B |
| Net non-operating interest income (expenses) | -159.48%-3.15B | -190.59%-8.59B | -12.27%5.3B | 66.88%9.48B | 132.00%6.13B | 22.55%-3.28B | -48.72%602M | -1.11%6.04B | -19.36%5.68B | -5.07%2.64B |
| Non-operating interest income | -58.59%4.16B | -55.57%8.55B | 0.26%10.05B | 78.58%19.24B | 135.67%8.83B | ---- | -37.20%2.96B | 37.70%10.02B | 2.93%10.77B | 5.76%3.75B |
| Non-operating interest expense | 54.01%7.31B | 75.71%17.14B | 19.27%4.75B | 91.63%9.75B | 144.47%2.7B | -33.83%3.28B | -33.38%2.36B | 240.46%3.98B | 48.87%5.09B | 45.45%1.1B |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -116.14%-51M | 21.97%1.02B | 586.96%316M | -5.34%833M | 17.29%346M | -9.34%233M | 6.19%206M | -65.15%46M | 81.07%880M | 54.45%295M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -38.40%10.32B | -57.42%30.88B | -32.81%16.76B | 29.74%72.51B | -40.93%11.31B | 90.91%19.69B | -4.26%16.58B | 173.61%24.94B | 27.21%55.89B | 18.34%19.15B |
| Income tax | -35.12%3.36B | -50.22%14.33B | -44.43%5.18B | 55.24%28.79B | 145.72%6.48B | 51.01%5.23B | 11.43%7.76B | 70.06%9.32B | -8.73%18.54B | -47.25%2.64B |
| Net income | -39.87%6.96B | -62.16%16.54B | -25.88%11.58B | 17.08%43.72B | -70.76%4.83B | 111.05%14.46B | -14.83%8.81B | 329.70%15.62B | 58.13%37.34B | 47.70%16.51B |
| Net income continuous operations | -39.87%6.96B | -62.16%16.54B | -25.88%11.58B | 17.08%43.72B | -70.76%4.83B | 111.05%14.46B | -14.83%8.81B | 329.70%15.62B | 58.13%37.34B | 47.70%16.51B |
| Noncontrolling interests | -40.94%453M | -18.34%2.83B | 19.84%767M | 13.01%3.47B | 73.94%981M | 54.65%1.16B | -45.23%683M | 26.98%640M | 4.60%3.07B | -9.90%564M |
| Net income attributable to the company | -39.79%6.51B | -65.94%13.71B | -27.83%10.81B | 17.45%40.26B | -75.88%3.85B | 118.00%13.3B | -10.67%8.13B | 378.42%14.98B | 65.72%34.28B | 51.11%15.94B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0.00%1M | 0 | 0.00%1M | 0 | 0 | 0 | 0 | 1M | 0 | 0 |
| Net income attributable to common stockholders | -39.79%6.51B | -65.94%13.71B | -27.83%10.81B | 17.45%40.26B | -75.88%3.85B | 118.04%13.3B | -10.67%8.13B | 378.38%14.98B | 65.73%34.28B | 51.11%15.94B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -35.14%20.45 | -65.61%40.36 | -27.83%31.53 | 17.44%117.37 | -75.89%11.21 | 118.05%38.77 | -10.70%23.7 | 378.53%43.69 | 65.71%99.94 | 51.09%46.49 |
| Diluted earnings per share | -35.13%20.44 | -65.62%40.34 | -27.85%31.51 | 17.44%117.32 | -75.88%11.21 | 118.06%38.75 | -10.67%23.69 | 378.31%43.67 | 65.73%99.9 | 51.12%46.47 |
| Dividend per share | 0 | 38.89%50 | 0 | 20.00%36 | 5.26%20 | 0 | 45.45%16 | 0 | 66.67%30 | 90.00%19 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |